Precigen, Inc. (PGEN)

6.90 -0.03 (-0.43%) USD  |  NASDAQ  |  Sep 01, 15:46
More

Precigen Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for PGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 06, 2026 --
August 05, 2026 --
July 27, 2026 --
June 30, 2026 --
June 12, 2026 --
June 01, 2026 --
May 28, 2026 --
May 15, 2026 --
May 14, 2026 --
March 26, 2026 --
December 31, 2025 --
December 29, 2025 --
November 14, 2025 --
November 07, 2025 --
October 13, 2025 --
September 30, 2025 --
September 25, 2025 --
Date Value
August 24, 2025 --
August 21, 2025 --
August 18, 2025 --
August 15, 2025 --
August 13, 2025 --
July 14, 2025 --
June 30, 2025 --
June 12, 2025 --
May 15, 2025 --
April 01, 2025 --
March 31, 2025 --
March 20, 2025 --
March 19, 2025 --
December 31, 2024 --
November 15, 2024 --
August 15, 2024 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Geron Corp. Upgrade
Neurocrine Biosciences, Inc. Upgrade
Elicio Therapeutics, Inc. Upgrade
Agenus, Inc. Upgrade
Amgen, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade